Cases & Deals

TxCell completes IPO on regulated market of Euronext in Paris

Clients TxCell SA

Jones Day advised TxCell SA, a biotech company specializing in innovative, personalized cell-based immunotherapies, in connection with its €16.2 million (US$22.4 million) initial public offering of Ordinary Shares on the regulated market of Euronext in Paris. Oddo & Cie and Société Générale acted as joint book-running managers.